Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -126,360 | -79,045 | -390,978 | -319,074 | -227,821 |
| Depreciation Amortization | 18,284 | 10,415 | 40,122 | 28,820 | 19,013 |
| Income taxes - deferred | -2,038 | -665 | -2,071 | -2,255 | 150 |
| Accounts receivable | -19,671 | 690 | -13,108 | 2,579 | 9,402 |
| Accounts payable and accrued liabilities | 4,070 | 15,888 | -6,661 | -1,448 | 2,945 |
| Other Working Capital | -48,718 | -12,884 | -24,266 | -16,973 | -8,599 |
| Other Operating Activity | 41,518 | -6,473 | 94,554 | 58,508 | 33,769 |
| Operating Cash Flow | $-132,915 | $-72,074 | $-302,408 | $-249,843 | $-171,141 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -50,607 | 18,002 | 81,332 | 71,237 | 43,381 |
| PPE Investments | -12,049 | -6,608 | -33,836 | -24,516 | -13,672 |
| Investing Cash Flow | $-62,656 | $11,394 | $47,496 | $46,721 | $29,709 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 148,968 | 98,514 | 307,832 | 251,215 | 162,693 |
| Other Financing Activity | -5,345 | -4,179 | -7,059 | -6,614 | -6,148 |
| Financing Cash Flow | $143,623 | $94,335 | $300,773 | $244,601 | $156,545 |
| Exchange Rate Effect | -337 | -213 | 1,144 | 567 | 1,247 |
| Beginning Cash Position | 169,058 | 169,058 | 122,053 | 122,053 | 122,053 |
| End Cash Position | 116,773 | 202,500 | 169,058 | 164,099 | 138,413 |
| Net Cash Flow | $-52,285 | $33,442 | $47,005 | $42,046 | $16,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,915 | -72,074 | -302,408 | -249,843 | -171,141 |
| Capital Expenditure | -12,049 | -6,608 | -33,836 | -24,516 | -13,672 |
| Free Cash Flow | -144,964 | -78,682 | -336,244 | -274,359 | -184,813 |